Work

Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation

Year: 2000

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s002800050017

Authors: John D. Roberts, Elizabeth A. Poplin, Mary Beth Tombes, Brenda Kyle, Darcy V. Spicer, Steven Grant, Timothy Synold, Richard Moran

Institutions: Virginia Commonwealth University, VCU Massey Comprehensive Cancer Center, Virginia Commonwealth University Medical Center, Rutgers Cancer Institute, University of Southern California, USC Norris Comprehensive Cancer Center

Language: English

Topic: Biochemical and Molecular Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, U.S. Public Health Service, National Cancer Institute

Awards: G163629551, G1683483650, G1786994590, NUCLEOTIDE DEPRIVATION-BASED SELECTIVE THERAPEUTICS, Massey Cancer Center - Cancer Center Support Grant

OpenAlex ID: W1975355830

FWCI: 1.239

Cites: 17

Cited by: 30

Related to: 10